Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Gordon Campbell | Parliament TV | Parliament Today | News Video | Crime | Employers | Housing | Immigration | Legal | Local Govt. | Maori | Welfare | Unions | Youth | Search

 

Flawed Greenpeace Chinese study no reason

Flawed Greenpeace Chinese study no reason for moratorium

“Expert analysis of the Greenpeace funded study of GM cotton in China, which has been touted as a reason for New Zealand extending its moratorium on the commercial release of GE, shows the interpretation of the study is seriously flawed,” the Chairman of the Life Sciences Network, Dr William Rolleston, said today.

“A call from GE-Free activists for the New Zealand Government to take a moral position as a result are misguided.

“The Greenpeace-funded study by the Nanjing Institute of Environmental Sciences is to be reviewed by the Chinese Academy of Sciences.

“Scientists who have already examined the study have scoffed at the claim it discloses significant environmental impacts from GM cotton.

“This is yet another example, in the hothouse climate created by the Green Party’s decision to make GE a key election issue, of the rush to negative judgement by the opponents of gene technology.

“They will seize on, and inflate enormously, any skerrick of information which seems to support their cause. By continually drumming up a false fear the activists will lose credibility as the public tires of their extremism,” concluded Dr Rolleston.


ENDS


Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

InfoPages News Channels


 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.